CRDF
Cardiff Oncology, Inc.
$1.25
-0.10 (-7.41%)
At close · Jul 8
Market Cap
$85.46M
Shares
68,369,896
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-04 | Jefferies Global Healthcare Conference | Conference |
| 2026-06-03 | Updated Phase 2 CRDF-004 Data for Onvansertib in First-Line RAS-Mutated mCRC | Event |
| 2026-03-25 | The Emergent Treatment Landscape: First-Line RAS-mutant Metastatic Colorectal Cancer | Event |
| 2026-03-04 | TD Cowen 46th Annual Health Care Conference | Conference |
| 2026-02-25 | Oppenheimer 36th Annual Healthcare Life Sciences Conference | Conference |
| 2026-01-27 | Cardiff Oncology, Inc. Conference Call | Conference |
| 2025-12-11 | Sidoti Events, LLC | Event |
| 2025-12-02 | Piper Sandler 37th Annual Healthcare Conference | Conference |
| 2025-11-12 | Stifel 2025 Healthcare Conference | Conference |
| 2025-11-11 | Guggenheim Securities 2nd Annual Healthcare Innovation Conference | Conference |
| 2025-10-09 | Noble Capital Markets’ Emerging Growth Virtual Equity Conference | Conference |
| 2025-09-09 | H.C. Wainwright 27th Annual Global Investment Conference | Conference |
| 2025-07-29 | CRDF-004 First-Line RAS-mutated mCRC Trial Update | Event |